Through 4 successful Joint Transnational Calls launched from 2009 to 2013, the EuroNanoMed ERA-NET initiative has allocated about € 32 Million to transnational research projects in Nanomedicine.
The ERA-NET EuroNanoMed II launches a fifth Joint Call for Proposals to support transnational innovative research projects in Nanomedicine. Thirteen countries/regions are participating to this call for proposals: Belgium/Flanders, Belgium/Wallonia, France, Israel, Italy, Latvia, Lithuania, Norway, Poland, Portugal, Romania, Spain and Sweden.
Research project consortia who intend to submit a transnational proposal should register from January 14th 2014, at https://www.pt-it.de/ptoutline/application/euronanomed2014, following the instructions provided on the site.
Registration and electronic proposal submission must be completed before Tuesday 4th March 2014 17:00:00 CET.
Veneto Nanotech S.C.P.A.
calloffice@euronanomed.net
+39 049 7705520
JTC 2014 Pre-eligibility check form for ITALIAN RESEARCHERS
The aims of the call are:
Project proposals will address multidisciplinary and translational research. The project proposals must cover at least one of the following areas that are equal in relevance for this call:
A consortium applying to this call must include research group(s) from at least two out of the three following categories, if eligible according to relevant national/regional funding organisation’s regulations for research funding:
Please note! Whilst applications will be submitted jointly by groups from several countries, individual groups will be funded by the individual EuroNanoMed II funding organization respective of the country/region from which applicants have applied. The applications are therefore subjected to eligibility criteria of individual funding organizations. Please note that the national eligibility conditions have evolved since the last EuroNanoMed call. Applicants are therefore strongly advised to contact their national representative as soon as possible in order to confirm their eligibility with their respective funding organizations.
Only transnational projects will be funded. Each proposal must involve a minimum of three research groups from three different countries including at least two eligible research groups from EuroNanoMed II country/regions participating in the 5th joint transnational call. The maximum number of participants in a project consortium is seven. Research groups not eligible to be funded (e.g. from non-funding countries or not fundable according to national/regional regulations of the participating funding countries) may participate in transnational projects if they are able to secure their own funding.
Participant organisation name | Country/region | Contact details |
Agentschap voor Innovatie door Wetenschap en Technologie (IWT) | BELGIUM / FLANDERS | dv@iwt.be
Dirk Veelaert (+32) 2 432 42 19 |
Fonds Wetenschappelijk Onderzoek (FWO) | BELGIUM/ FLANDERS | eranet@fwo.be
Olivier Boehme: (+32) 2 550 545 Geertrui Poelaert: (+32) 2 550 555 |
Service public de Wallonie (SPW-DGO6) | BELGIUM / WALLONIA | nicolas.delsaux@spw.wallonie.be
Nicolas Delsaux (+32) 81 33 45 20 |
Agence Nationale de la Recherche (ANR) | FRANCE | ENMIICoord@agencerecherche.fr
Heidi Ligeret (+33) 1 78 09 80 44 Natalia Martin (+33) 1 73 54 81 33 |
Chief Scientist Office, Ministry Of Health (CSO-MOH) | ISRAEL | Benny.Leshem@moh.health.gov.il
Benny Leshem (+972) (0) 2 5082161 |
Ministero Della Salute (IMH) | ITALY | g.guglielmi@sanita.it
Dr. Gaetano Guglielmi |
Latvijas Zinatnu Akademija (LAS) | LATVIA | dekhtyar@latnet.lv
Yuri Dekhtyar (+371) 670 89 383 Dace Tirzite (+371) 672 27 790 |
Lietuvos mokslo taryba (RCL) | LITHUANIA | jurgita.stonyte@lmt.lt
Jurgita Stonytė (+370) 5 261 8530 |
Norges Forskningsrad (RCN) | NORWAY | cam@forskningsradet.no
Cecilie Anita Mathiesen |
Narodowe Centrum Badan i Rozwoju (NCBR) | POLAND | dagmara.opoczynska-swiezewska@ncbr.gov.pl
Dagmara Opoczyńska-Świeżewska(+48) 22 39 07 177 |
Fundação para a Ciência e a Tecnologia (FCT) | PORTUGAL | carlos.pereira@fct.pt
Carlos Almeida Pereira (+351) 213924 397 |
Unitatea Executiva pentru Finantarea Invatamantului Superior, a Cercetarii, Dezvoltarii si Inovarii (UEFISCDI) | ROMANIA | mihaela.manole@uefiscdi.ro
Mihaela Manole (+40) 21 3023863 |
Instituto de Salud Carlos III (ISCIII) | SPAIN | era@isciii.es
Ignacio Baanante (+34) 9182 22576 |
Vetenskapsradet – Swedish Research Council (SRC) | SWEDEN | Johan.Nilsson@vr.se
Johan Nilsson (+46) 8 546 44 202 |
EuroNanoMed I & II call statistics
During the period 2009-2014, the ERA-NET EuroNanoMed I & II has successfully launched 5 joint calls for proposals.
The first 5 calls for proposals funded 40 transnational research projects on nanomedicine involving 217 partners from 21 countries/regions participating in the calls, with about € 38 million funding from the EuroNanoMed funding agencies and a further € 28 million funding from the research partners participating in the funded projects.
Country of origin of the applicants
Altogether, 914 partners from more than 21 countries participated in these calls, in a total of 192 submitted projects. As presented in figure 1, the number of applicants per country has globally grown between 2009 and 2014, as well as the number of submitted proposals (24 and 51 respectively).
Figure 1: Number of applicants per country for the first 5 calls for proposals.
*NPC (Non participating country) refers to applicants that belonged to countries where no funding organization participated in the joint transnational call.
Overview of the 5 calls
The table below summarizes the outcomes of the first 5 calls for proposals:
Participation of research organizations in translational projects in Nanomedicine
As EuroNanoMed I & II joint calls for proposals aimed at funding translational research projects in Nanomedicine, each consortium had to include teams from at least 2 of the following categories: academia, clinic/public health, industry. The distribution between these three categories among consortia funded in the 5 calls is outlined in Figure 2. Noteworthy, 61% of the funded projects included partners from all three categories, indicating the high added value of these collaborations in nanomedicine translational research.
Figure 2: Type of research organizations funded through the five EuroNanoMed I & II joint calls for proposals.
Scientific / technological areas covered by funded projects
The first 5 calls for proposals were open to projects covering at least one of the three priority topics of the European Technology Platform Nanomedecine: Targeted delivery systems, Diagnostics, Regenerative medicine. The coverage of these three scientific areas among funded projects is presented in figure 3.
Figure 3: Distribution of scientific areas covered by funded projects in the first 5 calls for proposals.
Ⓒ All rights reserved EuroNanoMed III, 2018